Dennis Watson to Proto-Oncogene Proteins c-ets
This is a "connection" page, showing publications Dennis Watson has written about Proto-Oncogene Proteins c-ets.
Connection Strength
2.866
-
Mechanisms and functional consequences of PDEF protein expression loss during prostate cancer progression. Prostate. 2011 Dec; 71(16):1723-35.
Score: 0.355
-
PDEF is a negative regulator of colon cancer cell growth and migration. J Cell Biochem. 2009 Dec 15; 108(6):1389-98.
Score: 0.325
-
MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. Cancer Res. 2008 Oct 15; 68(20):8499-506.
Score: 0.300
-
Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. Mol Biol Cell. 2008 Sep; 19(9):3745-57.
Score: 0.293
-
ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther. 2008 Jan; 8(1):33-42.
Score: 0.284
-
Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. Cancer Res. 2007 Feb 15; 67(4):1618-25.
Score: 0.267
-
ETS transcription factors and their emerging roles in human cancer. Eur J Cancer. 2005 Nov; 41(16):2462-78.
Score: 0.243
-
FLI1 expression is correlated with breast cancer cellular growth, migration, and invasion and altered gene expression. Neoplasia. 2014 Oct; 16(10):801-13.
Score: 0.114
-
Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression. J Biol Chem. 2010 Apr 09; 285(15):11258-69.
Score: 0.082
-
SP100 inhibits ETS1 activity in primary endothelial cells. Oncogene. 2005 Jan 27; 24(5):916-31.
Score: 0.058
-
Developmental expression pattern of D-ets4, the Drosophila homologue of human Pdef. Gene Expr Patterns. 2004 Dec; 5(2):285-9.
Score: 0.057
-
Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem. 2004 Dec 10; 279(50):52183-90.
Score: 0.057
-
Ets proteins in biological control and cancer. J Cell Biochem. 2004 Apr 01; 91(5):896-903.
Score: 0.055
-
Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. Cancer Res. 2003 Aug 01; 63(15):4626-31.
Score: 0.052
-
The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. Anticancer Res. 2003 May-Jun; 23(3A):2125-31.
Score: 0.051
-
Regulation of Ets function by protein - protein interactions. Oncogene. 2000 Dec 18; 19(55):6514-23.
Score: 0.044
-
FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements. Oncogene. 1997 Jan 16; 14(2):213-21.
Score: 0.033
-
Molecular analysis of the ets genes and their products. Crit Rev Oncog. 1990; 1(4):409-36.
Score: 0.020
-
A unique amino-terminal sequence predicted for the chicken proto-ets protein. Virology. 1988 Nov; 167(1):1-7.
Score: 0.019
-
Molecular organization of the chicken ets locus. Virology. 1988 May; 164(1):99-105.
Score: 0.018
-
Caspase-1 is a direct target gene of ETS1 and plays a role in ETS1-induced apoptosis. Cancer Res. 2005 Aug 15; 65(16):7205-13.
Score: 0.015
-
Interleukins 2 and 15 regulate Ets1 expression via ERK1/2 and MNK1 in human natural killer cells. J Biol Chem. 2005 Feb 11; 280(6):4772-8.
Score: 0.014
-
Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. J Immunol. 2004 Nov 15; 173(10):6481-9.
Score: 0.014
-
EAPII interacts with ETS1 and modulates its transcriptional function. Oncogene. 2003 May 08; 22(18):2699-709.
Score: 0.013
-
Ets1 is an effector of the transforming growth factor beta (TGF-beta ) signaling pathway and an antagonist of the profibrotic effects of TGF-beta. J Biol Chem. 2002 Jun 07; 277(23):20399-408.
Score: 0.012
-
EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene. 2000 Feb 10; 19(6):745-53.
Score: 0.010
-
Multiple regulatory regions control the expression of Ets-1 in the developing mouse: vascular expression conferred by intron I. Cell Mol Biol (Noisy-le-grand). 1997 Mar; 43(2):211-25.
Score: 0.008
-
Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation. Oncogene. 1996 Jan 04; 12(1):11-8.
Score: 0.008
-
The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins. Oncogene. 1994 Feb; 9(2):469-77.
Score: 0.007
-
Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. Oncogene. 1993 Jul; 8(7):1783-90.
Score: 0.006
-
Genomic dispersal of the ets gene family during metazoan evolution. Oncogene. 1992 Sep; 7(9):1713-9.
Score: 0.006
-
D-elg, a member of the Drosophila ets gene family: sequence, expression and evolutionary comparison. Oncogene. 1991 Jul; 6(7):1175-83.
Score: 0.006
-
The human ETS1 gene: genomic structure, promoter characterization and alternative splicing. Oncogene. 1991 Apr; 6(4):523-32.
Score: 0.006
-
Molecular and functional characterization of the promoter of ETS2, the human c-ets-2 gene. Proc Natl Acad Sci U S A. 1990 Feb; 87(3):1047-51.
Score: 0.005
-
ETS family of genes in leukemia and Down syndrome. Am J Med Genet Suppl. 1990; 7:251-61.
Score: 0.005
-
Expression of human and viral ets genes in E. coli production of human ets-2-specific monoclonal antibodies. Oncogene Res. 1989; 5(1):61-6.
Score: 0.005